Kinga Zielińska

Kinga Zielińska

Auto-generated profile, based on publicly available information

Kinga Zielińska

Małopolska Centre of Biotechnology, Jagiellonian University, Kraków, Poland

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 February 2024 in PLOS ONE
Verified
Journal Article
Open access
PDF file
KHKinga Humińska-Lisowska
Kinga Humińska-Lisowska
KZKinga Zielińska
Kinga Zielińska
Jan MieszkowskiJan Mieszkowski
Jan Mieszkowski
MMMonika Helena Michałowska-Sawczyn
Monika Helena Michałowska-Sawczyn
Pawel CieszczykPawel Cieszczyk
Pawel Cieszczyk
TKTomasz Kosciolek
Tomasz Kosciolek
The influence of human gut microbiota on health and disease is now commonly appreciated. Therefore, it is not surprising that microbiome research has found interest in the sports community, hoping to improve health and optimize performance. Comparative studies found new species or pathways that were more enriched in elites than sedentary controls. In addition, sport-specific and performance-level-specific microbiome features have been identified. However, the results remain inconclusive and indicate the need for further assessment. In this case-control study, we tested two athletic populations (i.e. strength athletes, endurance athletes) and a non-athletic, but physically active, control group across two acute exercise bouts, separated by a 2-week period, that measured explosive and high intensity fitness level (repeated 30-s all-out Wingate test (WT)) and cardiorespiratory fitness level (Bruce Treadmill Test). While we did not identify any group differences in alpha and beta diversity or significant differential abundance of microbiome components at baseline, one-third of the species identified were unique to each group. Longitudinal sample (pre- and post-exercise) analysis revealed an abundance of Alistipes communis in the strength group during the WT and 88 species with notable between-group differences during the Bruce Test. SparCC recognized Bifidobacterium longum and Bifidobacterium adolescentis, short-chain fatty acid producers with probiotic properties, species strongly associated with VO2max. Ultimately, we identified several taxa with different baseline abundances and longitudinal changes when comparing individuals based on their VO2max, average power, and maximal power parameters. Our results confirmed that the health status of individuals are consistent with assumptions about microbiome health. Furthermore, our findings indicate that microbiome features are associated with better performance previously identified in elite athletes.

6 January 2025 in GigaScience
Verified
Journal Article
Open access
KZKinga Zielińska
Kinga Zielińska
KUKlas I Udekwu
Klas I Udekwu
WRWitold Remigiusz Rudnicki
Witold Remigiusz Rudnicki
AFAlina Frolova
Alina Frolova
PLPawel Labaj
Pawel Labaj
Background: Microbiome-based disease prediction has significant potential as an early, noninvasive marker of multiple health conditions linked to dysbiosis of the human gut microbiota, thanks in part to decreasing sequencing and analysis costs. Microbiome health indices and other computational tools currently proposed in the field often are based on a microbiome’s species richness and are completely reliant on taxonomic classification. A resurgent interest in a metabolism-centric, ecological approach has led to an increased understanding of microbiome metabolic and phenotypic complexity, revealing substantial restrictions of taxonomy-reliant approaches. Findings: In this study, we introduce a new metagenomic health index developed as an answer to recent developments in microbiome definitions, in an effort to distinguish between healthy and unhealthy microbiomes, here in focus, inflammatory bowel disease (IBD). The novelty of our approach is a shift from a traditional Linnean phylogenetic classification toward a more holistic consideration of the metabolic functional potential underlining ecological interactions between species. Based on well-explored data cohorts, we compare our method and its performance with the most comprehensive indices to date, the taxonomy-based Gut Microbiome Health Index (GMHI), and the high-dimensional principal component analysis (hiPCA) methods, as well as to the standard taxon- and function-based Shannon entropy scoring. After demonstrating better performance on the initially targeted IBD cohorts, in comparison with other methods, we retrain our index on an additional 27 datasets obtained from different clinical conditions and validate our index's ability to distinguish between healthy and disease states using a variety of complementary benchmarking approaches. Finally, we demonstrate its superiority over the GMHI and the hiPCA on a longitudinal COVID-19 cohort and highlight the distinct robustness of our method to sequencing depth. Conclusions: Overall, we emphasize the potential of this metagenomic approach and advocate a shift toward functional approaches to better understand and assess microbiome health as well as provide directions for future index enhancements. Our method, q2-predict-dysbiosis (Q2PD), is freely available (https://github.com/Kizielins/q2-predict-dysbiosis).

1 October 2025 in Journal of Human Kinetics
Verified
Journal Article
Open access
KZKinga Zielińska
Kinga Zielińska
PLPawel Labaj
Pawel Labaj
KHKinga Humińska-Lisowska
Kinga Humińska-Lisowska
The human gut microbiome, a diverse community of microorganisms, plays a crucial role in digestion, metabolism, immune function, and brain health. Key metabolites produced by the gut microbiota, such as short-chain fatty acids (SCFAs) and bile acids, are essential for energy production, metabolic regulation, and immune system modulation. The gut microbiome's composition is influenced by factors including diet, exercise, sleep, and age, and disruptions are linked to various health conditions. Elite athletes exhibit unique gut microbiota profiles that contribute to their exceptional performance and recovery. Their microbiomes are not only richer, but also possess unique microorganisms and functional capabilities, alongside distinct genetic landscapes that support their high-level physiological demands. This review focuses specifically on the athletic gut microbiome, exploring how it differs from that of an active or a sedentary individual, adapts to different training phases, extreme conditions like heat and hypoxia, and prolonged exertion. It highlights the dual role of the gut microbiome in both enhancing athletic performance and potentially contributing to disease development, particularly due to the prolonged exertion and stress associated with years of intense competition. The review also explores the implications of microbiome changes following periods of intense physical activity and their impact on the athlete's overall health. Finally, it evaluates athlete-specific interventions, including prebiotics, probiotics, and synbiotics, aimed at mitigating negative effects on the gut microbiome while supporting health and optimizing performance.

28 November 2024 in bioRxiv
Verified
Preprint
Open access
PDF file
AWAlicja W. Wojciechowska
Alicja W. Wojciechowska
JWJakub W. Wojciechowski
Jakub W. Wojciechowski
KZKinga Zielinska
Kinga Zielinska
JSJohannes Soeding
Johannes Soeding
TKTomasz Kosciolek
Tomasz Kosciolek
MKMalgorzata Kotulska
Malgorzata Kotulska
Amyloids are insoluble protein aggregates with a cross-beta structure, which are traditionally associated with neurodegeneration. Similar structures, named functional amyloids, expressed mostly by microorganisms, play important physiological roles, e.g. bacterial biofilm stabilization. Using a bioinformatics approach, we identify gut microbiome functional amyloids and analyze their potential impact on human health via the gut-brain axis. The results point to taxonomically diverse sources of functional amyloids and their frequent presence in the extracellular space. The retrieved interactions between gut microbiome functional amyloids and human proteins indicate their potential to trigger inflammation, affect transport and signaling processes. We also find a greater relative abundance of bacterial functional amyloids in patients diagnosed with Parkinson’s disease and specifically a higher content of the curli amyloid protein, CsgA, in Alzheimer’s disease patients than in healthy controls. Our results provide a rationale for the tentative link between neurodegeneration and gut bacterial functional amyloids.

23 June 2026 in mSystems
Verified
Journal Article
Open access
KZKinga Zielińska
Kinga Zielińska
KPKateryna Pantiukh
Kateryna Pantiukh
EOElin Org
Elin Org
PLPawel Labaj
Pawel Labaj
TKTomasz Kosciolek
Tomasz Kosciolek
Next-generation sequencing has revolutionized microbiome research, yet the transition from taxonomic to functional profiling remains a major technical challenge. While marker gene sequencing provides a widely accessible ecological view, it often lacks the resolution for actionable insights. This perspective argues that shifting to whole metagenomic sequencing is essential for mapping functional potential, such as antimicrobial resistance, and metabolic pathways. However, we identify a critical bottleneck: excessive multiplexing. High multiplexing ratios reduce the number of unique molecules per sample, leading to high duplication rates and the stochastic dropout of low-abundance genes. We demonstrate that functional profiles are far more sensitive to these library complexity issues than taxonomic ones. We recommend prioritizing total sequencing depth and reducing multiplexing to ensure sufficient unique coverage. Additionally, adopting long-read or hybrid architectures is vital for providing the genomic context necessary for strain-level resolution. These optimizations are prerequisites for robust global microbiome synthesis and translational science.

5 December 2023 in bioRxiv
Verified
Preprint
Open access
PDF file
KZKinga Zielińska
Kinga Zielińska
KUKlas I. Udekwu
Klas I. Udekwu
WRWitold Remigiusz Rudnicki
Witold Remigiusz Rudnicki
AFAlina Frolova
Alina Frolova
PLPawel Labaj
Pawel Labaj
TKTomasz Kosciolek
Tomasz Kosciolek
Microbiome-based disease prediction has significant potential as an early, non-invasive marker of multiple health conditions linked to dysbiosis of the human gut microbiota, thanks in part to decreasing sequencing and analysis costs. Microbiome health indices and other computational tools currently proposed in the field often are based on a microbiome’s species richness and are completely reliant on taxonomic classification. A resurgent interest in a metabolism-centric, ecological approach has led to an increased understanding of microbiome metabolic and phenotypic complexity revealing substantial restrictions of taxonomy-reliant approaches. In this study, we introduce a new metagenomic health index developed as an answer to recent developments in microbiome definitions, in an effort to distinguish between healthy and unhealthy microbiomes, here in focus, inflammatory bowel disease (IBD). The novelty of our approach is a shift from a traditional Linnean phylogenetic classification towards a more holistic consideration of the metabolic functional potential underlining ecological interactions between species. Based on well-explored data cohorts, we compare our method and its performance with the most comprehensive indices to date, the taxonomy-based Gut Microbiome Health Index ( GMHI ), and the high dimensional principal component analysis ( hiPCA) methods, as well as to the standard taxon-, and function-based Shannon entropy scoring. After demonstrating better performance on the initially targeted IBD cohorts, in comparison with other methods, we retrain our index on an additional 27 datasets obtained from different clinical conditions and validate our index’s ability to distinguish between healthy and disease states using a variety of complementary benchmarking approaches. Finally, we demonstrate its superiority over the GMHI and the hiPCA on a longitudinal COVID-19 cohort and highlight the distinct robustness of our method to sequencing depth. Overall, we emphasize the potential of this metagenomic approach and advocate a shift towards functional approaches in order to better understand and assess microbiome health as well as provide directions for future index enhancements. Our method, q2-predict-dysbiosis (Q2PD) , is freely available ( https://github.com/Kizielins/q2-predict-dysbiosis ).